Access & prescription
No cannabis prescription issued: reasons and possible next steps
Not every assessment ends with a prescription. Why a doctor may decide against cannabis and which options are open to you afterwards.
Key points
- There is no entitlement to a cannabis prescription. The doctor decides on their own responsibility after an individual assessment.
- Common reasons for a no are contraindications such as certain pre-existing mental illnesses or heart disease, interactions, pregnancy or standard therapies that have not yet been exhausted.
- Depending on the complaint, the evidence for cannabis medicines is limited. A guideline on chronic pain recommends a trial only weakly and only as an add-on to standard treatment.
- A second opinion is possible. For this, bring the documents and the reasons given in the first assessment.
If your cannabis prescription has been refused, this means that the doctor does not consider a cannabis medicine medically justifiable in your current situation. There is no entitlement to a prescription. Since August 2022, responsibility for the treatment has rested exclusively with the treating doctor.1
A no is not a judgement about your complaints. Ask for the reasons, discuss other treatment options and get a second opinion if needed. Do not change your existing medicines yourself during this phase.
Why a cannabis prescription may be refused
Doctors prescribe cannabis medicines on their own responsibility, like other narcotics. They must weigh up the benefits and risks for you personally.1,2 Typical reasons for a no are:
- Contraindications: with certain pre-existing mental illnesses, such as psychoses, during pregnancy and breastfeeding or with severe cardiovascular disease, doctors often advise against THC. More on this in the article Cannabis medicine with pre-existing mental illness.
- Interactions: some medicines, for example benzodiazepines, opioids or certain antidepressants, can increase tiredness or other side effects together with cannabis. An overview is given in Interactions of THC and CBD.
- Standard therapies not exhausted: if there are better-studied treatments for your complaints that have not yet been tried, these usually come first.
- Limited evidence: for some complaints there are hardly any meaningful studies on cannabis medicines.
- Incomplete documents: if diagnoses or reports are missing, the doctor may not yet be able to assess the situation.
What the evidence on cannabis medicines shows
One reason for caution is the evidence. A review of 79 randomised trials found moderate-quality evidence for use in chronic pain and spasticity. For nausea during chemotherapy, sleep disorders and other uses, the quality of evidence was low. Short-term side effects were more common with cannabinoids, including dizziness, dry mouth, tiredness and nausea.3
A more recent meta-analysis on chronic pain with 32 trials and 5174 adults concluded that non-inhaled cannabis medicines led to a small to very small improvement in pain, physical function and sleep compared with placebo. At the same time, transient side effects occurred more often, especially dizziness.4
The guideline in the BMJ based on this makes a weak recommendation: to offer a trial of non-inhaled cannabis medicines in addition to standard treatment, if that is not sufficient.5 A weak recommendation means that the decision depends strongly on the individual person. This explains why doctors may decide differently for similar complaints.
79
Making use of the conversation after a no
Ask for an understandable explanation. Helpful questions are:
- Which reason was decisive: a contraindication, an interaction or missing previous treatments?
- Does the no apply in principle or only to the current situation?
- Which assessments or treatments would make sense next?
- Is a report to the family doctor’s practice needed?
Ask for a written summary if needed. Doctors must record their findings and measures in any case.8 A summary makes the next step easier for you, whether at your family doctor’s practice or for a second opinion.
Second opinion after a refused cannabis prescription
You may ask another doctor for an assessment. Since 2022, in principle any doctor can prescribe cannabis medicines, but they too decide on their own responsibility.1,2 A second opinion makes most sense if the first assessment was brief, important documents were missing or the doctor had little experience with cannabis medicines.
Be open about the first assessment and its reasons. Doctors may only prescribe for patients they have examined personally.6 A second opinion is therefore a separate, complete assessment, not a formality. If several doctors have advised against it for the same reasons, that is an important sign you should take seriously.
Discussing other therapies
A no to cannabis does not mean there is no treatment. Depending on the complaint, other medicines, physiotherapy, psychotherapy, a pain clinic or multimodal programmes may be considered, for example. For chronic pain, the BMJ guideline also sees cannabis only as an add-on if standard treatment is not sufficient.5
According to the FOPH, cannabis medicines are used in practice mainly for chronic pain, spasticity in multiple sclerosis or other neurological diseases, and nausea and loss of appetite during chemotherapy.7 If your complaints lie outside these areas, the evidence is often thinner.
Important: never change or stop existing medicines yourself, only in consultation with your doctor. With benzodiazepines, antidepressants, opioids or blood pressure medicines, stopping abruptly can be dangerous, so only do so with medical supervision. If you are struggling mentally, you can reach Die Dargebotene Hand at any time on 143.
When a new assessment makes sense
A no often applies to the current situation. If it changes, a new assessment may make sense. Examples are new findings, a completed pregnancy or treatment attempts that have since proved insufficient. A change in medication can also change the assessment of interactions. Whether a prescription is then issued is again decided by the doctor after a new assessment.1
Costs and health insurance after a no
If no prescription is issued, there are no costs for a cannabis medicine. The consultation itself is a medical service. Cannabis medicines are not included in the list of benefits of basic health insurance; reimbursement can only be considered in individual cases with cost approval.2 If the health insurer refuses cost approval, that is something different from a medical no: in that case the doctor considers a therapy justifiable, but the insurer does not cover the costs. More on this in the section Costs.
How it works at evidena
At evidena, whether cannabis therapy can be considered is decided exclusively by the doctor in the video consultation. Each case is considered individually; a prescription is not guaranteed. If one is issued, it must be filled at a pharmacy within one month. As a rule, the prescribed quantity covers one month, in justified cases at most three months of treatment.6
If there is no indication, the first consultation is not charged. Prices are shown on the page Costs, and further answers are in the frequently asked questions. You can book an appointment at https://portal.evidena.care/appointments. We answer questions via WhatsApp or at info@evidena.care.
Conclusion
If no cannabis prescription is issued, the doctor has weighed up the benefits and risks for you. Ask for the reasons to be explained and discuss other treatments. A second opinion is possible, but a different result is not guaranteed. Change existing medicines only in consultation with your doctor.
Frequently asked questions
Do I have a right to a cannabis prescription?
No. Since 2022, responsibility for the treatment lies with the doctor. After an assessment, the doctor decides whether a cannabis medicine is medically justifiable.
May I get a second opinion?
Yes. Inform the second doctor openly about the first assessment and its reasons. A different result is not guaranteed.
Can a no later become a yes?
That is possible if your situation changes, for example after further treatment attempts or new findings. The doctor will assess this again.
Should I change my current medicines after a no?
Never change or stop medicines yourself, only in consultation with your doctor. With some medicines, stopping abruptly is dangerous.
Do I have to pay for the consultation if no prescription is issued?
In principle, the consultation is a medical service, regardless of the outcome. At evidena, the first consultation is not charged if there is no indication. Prices are shown on the Costs page.
Sources
- Gesetzesänderung Cannabisarzneimittel, Bundesamt für Gesundheit BAG (accessed 13 November 2026)
- FAQ Cannabisarzneimittel, Bundesamt für Gesundheit BAG, 4. März 2025 (accessed 13 November 2026)
- Whiting PF et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA. 2015;313(24):2456-73. doi:10.1001/jama.2015.6358
- Wang L et al. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials. BMJ. 2021;374:n1034. doi:10.1136/bmj.n1034
- Busse JW et al. Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline. BMJ. 2021;374:n2040. doi:10.1136/bmj.n2040
- Betäubungsmittelkontrollverordnung (BetmKV), SR 812.121.1, Art. 46 und 47, Stand am 23. Januar 2023, Fedlex (accessed 13 November 2026)
- Medizinische Anwendung von Cannabis, Bundesamt für Gesundheit BAG (accessed 13 November 2026)
- Standesordnung der FMH, Art. 12 Aufzeichnungspflicht, Fassung November 2025 (accessed 13 November 2026)